ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08945
-0,01%
Bitcoin
67.375,80
0,44%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Rezolute Inc (RZLT)

  7. Rezolute Inc (RZLT) News

RZLT

Rezolute (RZLT)

Rezolute Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:RZLT
DatumZeitQuelleÜberschriftSymbolFirma
17/05/202422h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
15/05/202422h25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RZLTRezolute Inc
15/05/202422h05GlobeNewswire Inc.Rezolute Reports Third Quarter Fiscal 2024 Financial Results and Provides Business UpdateNASDAQ:RZLTRezolute Inc
23/04/202414h00GlobeNewswire Inc.Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual MeetingNASDAQ:RZLTRezolute Inc
11/03/202422h03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
11/03/202415h35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
06/03/202413h30GlobeNewswire Inc.Rezolute Reports Validation of the Potential Use of RZ358 for Treatment of Non-Islet Cell Tumor Hypoglycemia (NICTH)NASDAQ:RZLTRezolute Inc
27/02/202414h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
22/02/202423h00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
21/02/202417h55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
13/02/202423h00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:RZLTRezolute Inc
13/02/202422h20Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RZLTRezolute Inc
13/02/202422h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
13/02/202422h05GlobeNewswire Inc.Rezolute Reports Second Quarter Fiscal 2024 Results and Provides Business UpdateNASDAQ:RZLTRezolute Inc
29/01/202423h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
25/01/202418h36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
25/01/202418h10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
25/01/202418h06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
25/01/202418h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RZLTRezolute Inc
24/01/202414h00GlobeNewswire Inc.Rezolute Expands Leadership Team with Appointment of Daron Evans, MS, MBA, as Chief Financial OfficerNASDAQ:RZLTRezolute Inc
23/01/202414h00GlobeNewswire Inc.Rezolute Receives Innovation Passport Designation from the U.K. Innovative Licensing and Access Pathway Steering Group for RZ358 in the Treatment of Hypoglycemia Due to Congenital HyperinsulinismNASDAQ:RZLTRezolute Inc
14/12/202322h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
14/12/202314h00GlobeNewswire Inc.Rezolute Initiates Phase 3 Clinical Study for RZ358 in Congenital HyperinsulinismNASDAQ:RZLTRezolute Inc
13/12/202314h00GlobeNewswire Inc.Rezolute Completes Enrollment of its Phase 2 Study in Diabetic Macular Edema (“DME”)NASDAQ:RZLTRezolute Inc
30/11/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RZLTRezolute Inc
22/11/202323h16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:RZLTRezolute Inc
22/11/202322h35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RZLTRezolute Inc
17/11/202314h00GlobeNewswire Inc.Rezolute to Participate in BTIG’s 3rd Annual Ophthalmology DayNASDAQ:RZLTRezolute Inc
15/11/202315h08Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RZLTRezolute Inc
13/11/202322h21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RZLTRezolute Inc
 Showing the most relevant articles for your search:NASDAQ:RZLT

Kürzlich von Ihnen besucht

NASDAQ
ORSN
Orisun Acqusition
BIT
S31922
Societe Generale Effekten
NASDAQ
CRKN
Crown Electrokinetics
XE
EAD
Erlebnis Akademie
NASDAQ
STLYR
BOV
PETRQ231
PETRQ231 Ex:16,12
COIN
XDEF2ETH
xDEF Finance
BIT
S31342
Societe Generale Effekten
BIT
S32524
Societe Generale Effekten
EU
AGBAA
Natixis Assurances Fixed...
BIT
P21431
NLBNPIT21431 20240515 5400
BIT
P1YJY2
NLBNPIT1YJY2 20991231 46...
TG
CBR
Chiba Bank
USOTC
VTCHF
VerticalScope (PK)
BIT
P20WP3
NLBNPIT20WP3 20240621 210
EU
H853S
H853S
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten